Premium
A Pune-based drugmaker that counts two private equity firms as investors and recently started selling a medicine to treat COVID-19......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
